Iron-restricted medical disorders caused by excessive hepcidin, e.g., in ACD, iron-refractory iron deficiency anemia (IRIDA), or anemia of chronic kidney disease, are lacking suitable therapeutic options, and the current treatment strategies are accompanied by undesired side effects (1). The gene discussed is HAMP; the disease is anemia (phenotype).